By Dr. Manas Chakrabarti, FRCOG - Gynaecological Oncologist, Kolkata
In brief: This article covers three emerging treatment options for uterine fibroids - Uterine Artery Embolisation, MRgFUS, and experimental biological therapies. These are not replacements for established surgical and medical treatments, but options worth understanding. Read this alongside the companion articles on fibroid medical treatment and surgical treatment for the complete picture.
📋 Before You Read This
If you have already read the companion articles on fibroid medical treatment and surgical treatment, this article will make far more sense. The treatments described here are newer - and newer does not automatically mean better.
What it does mean is that you deserve to know these options exist.
The right treatment for any individual depends on her specific situation: the size, location, and number of fibroids; her desire for future pregnancy; her tolerance for risk; and her own preferences. Your doctor will discuss all of this with you, weighing the benefits and limitations of each approach honestly.
This article gives you the background to have that conversation well.
ℹ️ Why These Treatments Attract Attention
Most patients, when they first hear about fibroid surgery, ask the same quiet question: Is there really no other way?
It is a reasonable thing to wonder. The idea of a procedure that does not involve cutting, scarring, or a long recovery is genuinely appealing - and for some patients, some of the time, these newer options do deliver on that promise.
The important word is some. Each of the three approaches described below carries its own profile of benefits, limitations, and unanswered questions. Science is still learning.
ℹ️ Uterine Artery Embolisation
🔷 What It Is
Uterine Artery Embolisation (UAE) is a radiology procedure, not an abdominal operation. There is no surgical incision.
A thin, flexible tube is guided through a blood vessel in the patient’s thigh - using live scan imaging for precision - until it reaches the blood vessels supplying the uterus.
Because fibroids depend on uterine blood flow for their survival, the next step is deliberate: small chemical particles are used to block the blood vessel branches that feed the fibroid. Deprived of blood and nutrients, the fibroid gradually dies and shrinks - while remaining inside the body.
🔷 Why Patients Find It Appealing
Recovery time is shorter than conventional surgery. There is no abdominal wound. For women who cannot or do not wish to undergo a general anaesthetic and surgical procedure, UAE offers a meaningful alternative.
🔷 What the Evidence Shows
The evidence, however, asks for caution alongside the enthusiasm.
Research shows that within 30 months of UAE, approximately 17 in every 100 women experience a return of fibroid symptoms and require further treatment. This is not a small proportion.
Side effects are also possible. As the fibroid breaks down, chemical by-products can cause fever-like symptoms. Some women experience lower abdominal pain or irregular vaginal bleeding in the weeks following the procedure. In a small number of cases, these complications become severe enough to require surgical removal of the uterus.
As of now, if you are hoping to become pregnant in the future, UAE might not be the best option for you. A growing baby requires robust uterine blood supply - reducing that supply can compromise pregnancy. Research in this area is ongoing, and your doctor will advise you based on the most current evidence.
ℹ️ Magnetic Resonance-Guided Focused Ultrasound Surgery
🔷 What It Is
MRgFUS - Magnetic Resonance-guided Focused Ultrasound Surgery - is the treatment many patients dream about before they know its name.
The concept is exactly what it sounds like: MRI imaging identifies the precise location of the fibroid, and then tightly focused, high-intensity sound waves are directed at it from outside the body. No incision. No instrument inserted into the uterus. The fibroid is, in effect, heated and destroyed from the outside.
Several centres across India now offer this facility.
🔷 What the Evidence Shows
The honest picture is more complicated than the concept.
A 2014 study by Quinn and colleagues found that whilst MRgFUS produced initially satisfying results, approximately 70 in every 100 patients required further surgical intervention within a short period. That figure is significant, and it is why most gynaecological oncologists remain cautious.
Post-procedure side effects can include lower abdominal pain and heavy bleeding. In some cases, the focused sound waves have affected surrounding organs or nerves - including, in rare instances, the sciatic nerve, causing leg and lower back pain.
Research into MRgFUS is continuing, and outcomes are expected to improve as targeting precision advances. Your doctor will advise you on whether current evidence supports this option for your specific situation.
The science is not yet settled. But it is moving forward.
ℹ️ Nanotechnology and Biological Therapies
🔷 What Is Being Explored
A third category of treatment is still firmly in the research phase - but it is worth knowing it exists, because it points to where fibroid treatment may be heading in the coming decades.
Two approaches are currently under investigation.
The first uses nanotechnology as a delivery system: specially engineered viral carriers are designed to transport genetic therapy directly into fibroid tissue, targeting the cells responsible for fibroid growth at a molecular level.
The second involves a naturally occurring enzyme derived from Clostridium histolyticum - a type of bacterium. When injected directly into fibroid tissue, this enzyme has been shown, in early research, to help break down fibroid structure.
🔷 Where the Science Stands
Both approaches remain experimental. Practical, peer-reviewed results in human patients are still emerging.
These are not treatments currently available in standard clinical practice. They are mentioned here because an informed patient deserves to know the direction science is travelling - not because they represent options you can pursue today.
Within the next two to three decades, as this research matures, clinicians and patients will have far clearer guidance on who benefits from these approaches, and how safely they can be delivered.
ℹ️ The Most Important Thing to Remember
New is not the same as best.
Every treatment described in this article has genuine appeal - and every one of them also has limitations that established surgical options do not share. The fact that something does not involve a surgical incision does not mean it carries no risk. It means the risks are different.
The right choice is the one made with full information, in conversation with a doctor who knows your history, your priorities, and the current state of the evidence.
If you are living with fibroids and weighing your options, that conversation is the most important next step - not a further search online.
📋 In Summary
UAE blocks the blood supply to fibroids, causing them to shrink - but carries a meaningful recurrence rate and is not recommended for women planning future pregnancies.
MRgFUS destroys fibroids using focused sound waves without surgery - but current evidence shows a high rate of re-intervention within a short period.
Nanotechnology and enzyme-based therapies are promising experimental approaches, not yet available in standard practice.
No single treatment is right for every patient. The decision depends on your individual circumstances, wishes, and the honest assessment of your gynaecologist.
Dr. Manas Chakrabarti, FRCOG, is a senior gynaecological oncologist based in Kolkata, a Cochrane author, and a specialist in complex gynaecological and gynaecological-oncological surgery. Patients travel from across India, the Middle East, and Europe for his care.
🔷 Further Reading
Fibroid Treatment Guide: 9 Steps Before Going to Doctor
Masterclass: Fibroid
Quinn, S.D. et al. (2014). Re-intervention rates after uterine-sparing interventions for fibroids. - for your doctor’s reference
This is an impartial , unsponsored health information. For public awareness and not a replacement of Medical Advice.